Daiwa Securities Group
RVMD icon

Daiwa Securities Group’s Revolution Medicines RVMD Stock Holding History

Daiwa Securities Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.91M Buy
19,604
+12,769
+187% +$1.29M 0.01% 658
2025
Q4 		$545K Sell
6,835
-2
-0% -$131 ﹤0.01% 872
2025
Q3 		$319K Sell
6,837
-998
-13% -$39.1K ﹤0.01% 943
2025
Q2 		$288K Buy
7,835
+3,689
+89% +$142K ﹤0.01% 920
2025
Q1 		$147K Buy
4,146
+359
+9% +$14.6K ﹤0.01% 953
2024
Q4 		$165K Buy
3,787
+3,178
+522% +$160K ﹤0.01% 954
2024
Q3 		$28K Hold
609
– – ﹤0.01% 1090
2024
Q2 		$24K Hold
609
– – ﹤0.01% 1130
2024
Q1 		$20K Sell
609
-61
-9% -$1.81K ﹤0.01% 1138
2023
Q4 		$19K Buy
670
+313
+88% +$7.52K ﹤0.01% 1131
2023
Q3 		$10K Hold
357
– – ﹤0.01% 1128
2023
Q2 		$10K Hold
357
– – ﹤0.01% 1139
2023
Q1 		$8K Hold
357
– – ﹤0.01% 1126
2022
Q4 		$9K Buy
357
+80
+29% +$1.7K ﹤0.01% 1119
2022
Q3 		$5K Hold
277
– – ﹤0.01% 1163
2022
Q2 		$5K Buy
277
+62
+29% +$1.21K ﹤0.01% 1172
2022
Q1 		$5K Hold
215
– – ﹤0.01% 1177
2021
Q4 		$5K Sell
215
-37
-15% -$1.04K ﹤0.01% 1203
2021
Q3 		$7K Buy
252
+109
+76% +$3.17K ﹤0.01% 1160
2021
Q2 		$5K Hold
143
– – ﹤0.01% 1078
2021
Q1 		$7K Buy
143
+18
+14% +$807 ﹤0.01% 1061
2020
Q4 		$5K Buy
+125
New +$4.94K ﹤0.01% 1057

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Daiwa Securities Group's RVMD Position: Q1 2026 in Review

Daiwa Securities Group increased its Revolution Medicines (RVMD) stake by 187% in Q1 2026, buying an estimated $1.29M and bringing the position to 19,604 shares worth $1.91M. The position accounts for 0.01% of the portfolio, ranked #658.

Daiwa Securities Group first reported a position in RVMD in Q4 2020 and has held it in 22 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Daiwa Securities Group held 19,604 shares of Revolution Medicines worth $1.91M as of Q1 2026.
  • Daiwa Securities Group bought 12,769 Revolution Medicines shares in Q1 2026, an estimated $1.29M.
  • Revolution Medicines made up 0.01% of Daiwa Securities Group's portfolio in Q1 2026, its #658 holding.
  • Daiwa Securities Group first reported a position in Revolution Medicines in Q4 2020 and has held it in 22 quarters since.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.